Yu, Meixiang

Publications

Sort by

Co-Author Network

selected publications

Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons. Neurobiology of aging. 2011 Academic Article GET IT
Times cited: 95
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 2009 Academic Article GET IT
Times cited: 650
Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2007 Academic Article GET IT
Times cited: 54
Positron emission tomography of herpes simplex virus 1 oncolysis. Cancer research. 2007 Academic Article GET IT
Times cited: 36
Evaluation of four pyridine analogs to characterize 6-OHDA-induced modulation of mGluR5 function in rat brain using microPET studies. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2007 Academic Article GET IT
Times cited: 19
Dual-modality in vivo monitoring of subventricular zone stem cell migration and metabolism. Contrast media & molecular imaging. 2007 Academic Article GET IT
Times cited: 21
Recent developments of the PET imaging agents for metabotropic glutamate receptor subtype 5. Current topics in medicinal chemistry. 2007 Review GET IT
Times cited: 21
Human radiation dosimetry of [11C]MeAIB, a new tracer for imaging of system A amino acid transport. European journal of nuclear medicine and molecular imaging. 2006 Academic Article GET IT
Times cited: 14
Methoxyphenylethynyl, methoxypyridylethynyl and phenylethynyl derivatives of pyridine: synthesis, radiolabeling and evaluation of new PET ligands for metabotropic glutamate subtype 5 receptors. Nuclear medicine and biology. 2005 Academic Article GET IT
Times cited: 40
Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease. Journal of the neurological sciences. 2005 Academic Article GET IT
Times cited: 63
Biodistribution and blood metabolism of 1-11C-methyl-4-piperidinyl n-butyrate in humans: an imaging agent for in vivo assessment of butyrylcholinesterase activity with PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2004 Academic Article GET IT
Times cited: 21
3-Nitropropionic acid-induced neurotoxicity--assessed by ultra high resolution positron emission tomography with comparison to magnetic resonance spectroscopy. Journal of neurochemistry. 2004 Academic Article GET IT
Times cited: 28
Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease. Journal of neuroinflammation. 2004 Academic Article GET IT
Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model. NeuroImage. 2003 Academic Article GET IT
Times cited: 54
Radiolabeling and biodistribution of methyl 2-(methoxycarbonyl)-2-(methylamino) bicyclo[2.1.1] -hexane -5-carboxylate, a potential neuroprotective drug. Life sciences. 2003 Academic Article GET IT
Times cited: 5
Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease. Journal of neurology, neurosurgery, and psychiatry. 2003 Academic Article GET IT
Times cited: 143
Synthesis, radiolabeling and preliminary biological evaluation of radiolabeled 5-methyl-6-nitroquipazine, a potential radioligand for the serotonin transporter. Bioorganic & medicinal chemistry letters. 2002 Academic Article GET IT
Times cited: 18
Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease. Journal of clinical psychopharmacology. 2002 Academic Article GET IT
Times cited: 116
Amino acid uptake in the skeletal muscle measured using [11C]methylaminoisobutyrate (MEAIB) and PET. European journal of nuclear medicine and molecular imaging. 2002 Academic Article GET IT
Times cited: 11
PET examination of [(11)C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter. Nuclear medicine and biology. 2002 Academic Article GET IT
Times cited: 24
Metabolism of [123I]epidepride may affect brain dopamine D2 receptor imaging with single-photon emission tomography. European journal of nuclear medicine. 2000 Academic Article GET IT
Times cited: 5
Effect of radiochemical purity of 99Tcm-Q12 on myocardial SPET image quality. Nuclear medicine communications. 1999 Academic Article GET IT
Comparison of HPLC, TLC and minicolumn for measuring the radiochemical purity of 99Tcm-Q12. Nuclear medicine communications. 1998 Academic Article GET IT
Times cited: 3
Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging. European journal of nuclear medicine. 1998 Academic Article GET IT
Times cited: 49
Biodistribution of [64Cu]Cu2+ and variance of metallothionein during tumor treatment by copper. Nuclear medicine and biology. 1998 Academic Article GET IT
Times cited: 8
Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis. Molecular psychiatry. 1997 Academic Article GET IT
Times cited: 146

more ...

less ...

Background

education and training

Ph.D., Peking University (China) 1996
B.S., Peking University (China) 1990

Contact

full name

Meixiang Yu

VIVO Weill Cornell Medical College

Meixiang Yu Associate Professor of Radiochemistry Research in Radiology

Publications

selected publications

Background

education and training

Contact

full name